An Alternative Device for the Topical Treatment of Oral Cancer: Development and Ex-Vivo Evaluation of Imiquimod-Loaded Polysaccharides Formulations

The topical use of imiquimod (IMQ), a non-specific immune response modifier, showed to be a promising therapeutic option for the early-stage treatment of some type of oral cancer, even when performed with a formulation (Aldara(®)) developed and approved for skin application. The aim of this work was...

Descripción completa

Detalles Bibliográficos
Autores principales: Remiro, Paula de Freitas Rosa, Nagahara, Mariana Harue Taniguchi, Ghezzi, Martina, Filippini, Alessia, Demurtas, Anna, Pescina, Silvia, Santi, Patrizia, Padula, Cristina, Moraes, Ângela Maria, Nicoli, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785792/
https://www.ncbi.nlm.nih.gov/pubmed/36559066
http://dx.doi.org/10.3390/pharmaceutics14122573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785792/
https://www.ncbi.nlm.nih.gov/pubmed/36559066
http://dx.doi.org/10.3390/pharmaceutics14122573

Ejemplares similares